These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

719 related articles for article (PubMed ID: 26331372)

  • 1. Molecular evidence that invasive adenocarcinoma can mimic prostatic intraepithelial neoplasia (PIN) and intraductal carcinoma through retrograde glandular colonization.
    Haffner MC; Weier C; Xu MM; Vaghasia A; Gürel B; Gümüşkaya B; Esopi DM; Fedor H; Tan HL; Kulac I; Hicks J; Isaacs WB; Lotan TL; Nelson WG; Yegnasubramanian S; De Marzo AM
    J Pathol; 2016 Jan; 238(1):31-41. PubMed ID: 26331372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ERG and PTEN status of isolated high-grade PIN occurring in cystoprostatectomy specimens without invasive prostatic adenocarcinoma.
    Morais CL; Guedes LB; Hicks J; Baras AS; De Marzo AM; Lotan TL
    Hum Pathol; 2016 Sep; 55():117-25. PubMed ID: 27189342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ETS gene aberrations in atypical cribriform lesions of the prostate: Implications for the distinction between intraductal carcinoma of the prostate and cribriform high-grade prostatic intraepithelial neoplasia.
    Han B; Suleman K; Wang L; Siddiqui J; Sercia L; Magi-Galluzzi C; Palanisamy N; Chinnaiyan AM; Zhou M; Shah RB
    Am J Surg Pathol; 2010 Apr; 34(4):478-85. PubMed ID: 20220513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-grade prostatic intraepithelial neoplasia, PIN-like carcinoma, ductal carcinoma, and intraductal carcinoma of the prostate.
    Zhou M
    Mod Pathol; 2018 Jan; 31(S1):S71-79. PubMed ID: 29297491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PTEN genomic deletion is an early event associated with ERG gene rearrangements in prostate cancer.
    Bismar TA; Yoshimoto M; Vollmer RT; Duan Q; Firszt M; Corcos J; Squire JA
    BJU Int; 2011 Feb; 107(3):477-85. PubMed ID: 20590547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atypical Intraductal Cribriform Proliferations of the Prostate Exhibit Similar Molecular and Clinicopathologic Characteristics as Intraductal Carcinoma of the Prostate.
    Hickman RA; Yu H; Li J; Kong M; Shah RB; Zhou M; Melamed J; Deng FM
    Am J Surg Pathol; 2017 Apr; 41(4):550-556. PubMed ID: 28009609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromosomal imbalances, loss of heterozygosity, and immunohistochemical expression of TP53, RB1, and PTEN in intraductal cancer, intraepithelial neoplasia, and invasive adenocarcinoma of the prostate.
    Bettendorf O; Schmidt H; Staebler A; Grobholz R; Heinecke A; Boecker W; Hertle L; Semjonow A
    Genes Chromosomes Cancer; 2008 Jul; 47(7):565-72. PubMed ID: 18383208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of ERG protein, a prostate cancer specific marker, in high grade prostatic intraepithelial neoplasia (HGPIN): lack of utility to stratify cancer risks associated with HGPIN.
    He H; Osunkoya AO; Carver P; Falzarano S; Klein E; Magi-Galluzzi C; Zhou M
    BJU Int; 2012 Dec; 110(11 Pt B):E751-5. PubMed ID: 23046279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TMPRSS2-ERG gene fusion causing ERG overexpression precedes chromosome copy number changes in prostate carcinomas and paired HGPIN lesions.
    Cerveira N; Ribeiro FR; Peixoto A; Costa V; Henrique R; Jerónimo C; Teixeira MR
    Neoplasia; 2006 Oct; 8(10):826-32. PubMed ID: 17032499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Pathology of High-Grade Prostatic Intraepithelial Neoplasia: Challenges and Opportunities.
    Trabzonlu L; Kulac I; Zheng Q; Hicks JL; Haffner MC; Nelson WG; Sfanos KS; Ertunc O; Lotan TL; Heaphy CM; Meeker AK; Yegnasubramanian S; De Marzo AM
    Cold Spring Harb Perspect Med; 2019 Apr; 9(4):. PubMed ID: 30082453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is high-grade prostatic intraepithelial neoplasia (HGPIN) a reliable precursor for prostate carcinoma? Implications for clonal evolution and early detection strategies.
    Tolkach Y; Kristiansen G
    J Pathol; 2018 Apr; 244(4):389-393. PubMed ID: 29377129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Premalignancy in Prostate Cancer: Rethinking What we Know.
    De Marzo AM; Haffner MC; Lotan TL; Yegnasubramanian S; Nelson WG
    Cancer Prev Res (Phila); 2016 Aug; 9(8):648-56. PubMed ID: 26813971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diagnostic value of estimation of ERG expression in prostate adenocarcinoma and high-grade prostatic intraepithelial neoplasia].
    Allina DO; Kekeeva TV; Moskvina LV; Shikeeva AA; Andreeva YY; Zavalishina LE; Frank GA
    Arkh Patol; 2015; 77(5):36-42. PubMed ID: 26978019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ERG rearrangement for predicting subsequent cancer diagnosis in high-grade prostatic intraepithelial neoplasia and lymph node metastasis.
    Gao X; Li LY; Zhou FJ; Xie KJ; Shao CK; Su ZL; Sun QP; Chen MK; Pang J; Zhou XF; Qiu JG; Wen XQ; Yang M; Bai XZ; Zhang H; Ling L; Chen Z
    Clin Cancer Res; 2012 Aug; 18(15):4163-72. PubMed ID: 22696228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological analysis of intraductal proliferative lesions of prostate: intraductal carcinoma of prostate, high-grade prostatic intraepithelial neoplasia, and atypical cribriform lesion.
    Miyai K; Divatia MK; Shen SS; Miles BJ; Ayala AG; Ro JY
    Hum Pathol; 2014 Aug; 45(8):1572-81. PubMed ID: 24842280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutation Profiling Indicates High Grade Prostatic Intraepithelial Neoplasia as Distant Precursors of Adjacent Invasive Prostatic Adenocarcinoma.
    Gerrin SJ; Sowalsky AG; Balk SP; Ye H
    Prostate; 2016 Sep; 76(13):1227-36. PubMed ID: 27272561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of TMPRSS2-ERG fusion high-grade prostatic intraepithelial neoplasia and potential clinical implications.
    Mosquera JM; Perner S; Genega EM; Sanda M; Hofer MD; Mertz KD; Paris PL; Simko J; Bismar TA; Ayala G; Shah RB; Loda M; Rubin MA
    Clin Cancer Res; 2008 Jun; 14(11):3380-5. PubMed ID: 18519767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In situ and intraductal epithelial proliferations of prostate: definitions and treatment implications. Part 1: Prostatic intraepithelial neoplasia.
    Clouston D; Bolton D
    BJU Int; 2012 Apr; 109 Suppl 3():22-6. PubMed ID: 22458488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of PTEN and ERG immunostaining for distinguishing high-grade PIN from intraductal carcinoma of the prostate on needle biopsy.
    Morais CL; Han JS; Gordetsky J; Nagar MS; Anderson AE; Lee S; Hicks JL; Zhou M; Magi-Galluzzi C; Shah RB; Epstein JI; De Marzo AM; Lotan TL
    Am J Surg Pathol; 2015 Feb; 39(2):169-78. PubMed ID: 25517949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluorescence in situ hybridization study shows association of PTEN deletion with ERG rearrangement during prostate cancer progression.
    Han B; Mehra R; Lonigro RJ; Wang L; Suleman K; Menon A; Palanisamy N; Tomlins SA; Chinnaiyan AM; Shah RB
    Mod Pathol; 2009 Aug; 22(8):1083-93. PubMed ID: 19407851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.